Global Prophylactic Hepatitis B Virus Vaccines Market Research Report 2023

Report ID: 1992344 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hepatitis B
        1.2.3 Liver Cirrhosis
        1.2.4 Hepatocellular Carcinoma
        1.2.5 Liver Failure
    1.3 Market by Application
        1.3.1 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Perspective (2017-2028)
    2.2 Prophylactic Hepatitis B Virus Vaccines Growth Trends by Region
        2.2.1 Prophylactic Hepatitis B Virus Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Prophylactic Hepatitis B Virus Vaccines Market Dynamics
        2.3.1 Prophylactic Hepatitis B Virus Vaccines Industry Trends
        2.3.2 Prophylactic Hepatitis B Virus Vaccines Market Drivers
        2.3.3 Prophylactic Hepatitis B Virus Vaccines Market Challenges
        2.3.4 Prophylactic Hepatitis B Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue
        3.1.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Prophylactic Hepatitis B Virus Vaccines Revenue
    3.4 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio
        3.4.1 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prophylactic Hepatitis B Virus Vaccines Revenue in 2021
    3.5 Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Area Served
    3.6 Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
    3.7 Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Type
    4.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2023-2028)
5 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Application
    5.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size (2017-2028)
    6.2 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
    6.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size (2017-2028)
    7.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
    7.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
    8.3 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size (2017-2028)
    9.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
    9.3 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022)
    10.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Introduction
        11.1.4 Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Sanofi Pasteur
        11.2.1 Sanofi Pasteur Company Detail
        11.2.2 Sanofi Pasteur Business Overview
        11.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Introduction
        11.2.4 Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
        11.2.5 Sanofi Pasteur Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Introduction
        11.3.4 Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Introduction
        11.4.4 Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Company Detail
        11.5.2 GlaxoSmithKline Business Overview
        11.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Introduction
        11.5.4 GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
        11.5.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hepatitis B
    Table 3. Key Players of Liver Cirrhosis
    Table 4. Key Players of Hepatocellular Carcinoma
    Table 5. Key Players of Liver Failure
    Table 6. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2017-2022)
    Table 10. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2023-2028)
    Table 12. Prophylactic Hepatitis B Virus Vaccines Market Trends
    Table 13. Prophylactic Hepatitis B Virus Vaccines Market Drivers
    Table 14. Prophylactic Hepatitis B Virus Vaccines Market Challenges
    Table 15. Prophylactic Hepatitis B Virus Vaccines Market Restraints
    Table 16. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players (2017-2022)
    Table 18. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2021)
    Table 19. Ranking of Global Top Prophylactic Hepatitis B Virus Vaccines Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
    Table 23. Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2017-2022)
    Table 27. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2023-2028)
    Table 29. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2017-2022)
    Table 31. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2023-2028)
    Table 33. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Merck Company Detail
    Table 44. Merck Business Overview
    Table 45. Merck Prophylactic Hepatitis B Virus Vaccines Product
    Table 46. Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022) & (US$ Million)
    Table 47. Merck Recent Development
    Table 48. Sanofi Pasteur Company Detail
    Table 49. Sanofi Pasteur Business Overview
    Table 50. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product
    Table 51. Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022) & (US$ Million)
    Table 52. Sanofi Pasteur Recent Development
    Table 53. Novartis Company Detail
    Table 54. Novartis Business Overview
    Table 55. Novartis Prophylactic Hepatitis B Virus Vaccines Product
    Table 56. Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022) & (US$ Million)
    Table 57. Novartis Recent Development
    Table 58. Pfizer Company Detail
    Table 59. Pfizer Business Overview
    Table 60. Pfizer Prophylactic Hepatitis B Virus Vaccines Product
    Table 61. Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022) & (US$ Million)
    Table 62. Pfizer Recent Development
    Table 63. GlaxoSmithKline Company Detail
    Table 64. GlaxoSmithKline Business Overview
    Table 65. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product
    Table 66. GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022) & (US$ Million)
    Table 67. GlaxoSmithKline Recent Development
    Table 68. Research Programs/Design for This Report
    Table 69. Key Data Information from Secondary Sources
    Table 70. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. Hepatitis B Features
    Figure 3. Liver Cirrhosis Features
    Figure 4. Hepatocellular Carcinoma Features
    Figure 5. Liver Failure Features
    Figure 6. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Prophylactic Hepatitis B Virus Vaccines Report Years Considered
    Figure 10. Global Prophylactic Hepatitis B Virus Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Prophylactic Hepatitis B Virus Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region: 2021 VS 2028
    Figure 13. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players in 2021
    Figure 14. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue in 2021
    Figure 16. North America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2017-2028)
    Figure 18. United States Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2017-2028)
    Figure 22. Germany Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2017-2028)
    Figure 30. China Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2017-2028)
    Figure 38. Mexico Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2017-2028)
    Figure 42. Turkey Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Merck Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
    Figure 45. Sanofi Pasteur Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
    Figure 46. Novartis Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
Frequently Asked Questions
Prophylactic Hepatitis B Virus Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prophylactic Hepatitis B Virus Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prophylactic Hepatitis B Virus Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Propulsion System

Propulsion System market is segmented by players, region (country), by Type and by Application. P ... Read More